Turner CT - Search Results

1

Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I.

Kakavanos R, Turner CT, Hopwood JJ, Kakkis ED, Brooks DA. Kakavanos R, et al. Among authors: turner ct. Lancet. 2003 May 10;361(9369):1608-13. doi: 10.1016/S0140-6736(03)13311-9. Lancet. 2003. PMID: 12747881 Review.

2

Immune response to enzyme replacement therapy: single epitope control of antigen distribution from circulation.

Glaros EN, Turner CT, Parkinson EJ, Hopwood JJ, Brooks DA. Glaros EN, et al. Among authors: turner ct. Mol Genet Metab. 2002 Sep-Oct;77(1-2):127-35. doi: 10.1016/s1096-7192(02)00148-8. Mol Genet Metab. 2002. PMID: 12359140

3

Immune response to enzyme replacement therapy: 4-sulfatase epitope reactivity of plasma antibodies from MPS VI cats.

Turner CT, Hopwood JJ, Bond CS, Brooks DA. Turner CT, et al. Mol Genet Metab. 1999 Jul;67(3):194-205. doi: 10.1006/mgme.1999.2859. Mol Genet Metab. 1999. PMID: 10381327

4

Enzyme replacement therapy in mucopolysaccharidosis I: altered distribution and targeting of alpha-L-iduronidase in immunized rats.

Turner CT, Hopwood JJ, Brooks DA. Turner CT, et al. Mol Genet Metab. 2000 Apr;69(4):277-85. doi: 10.1006/mgme.2000.2979. Mol Genet Metab. 2000. PMID: 10870845

5

Drug induced exocytosis of glycogen in Pompe disease.

Turner CT, Fuller M, Hopwood JJ, Meikle PJ, Brooks DA. Turner CT, et al. Biochem Biophys Res Commun. 2016 Oct 28;479(4):721-727. doi: 10.1016/j.bbrc.2016.09.145. Epub 2016 Sep 28. Biochem Biophys Res Commun. 2016. PMID: 27693584

6

Analysis of normal and mutant iduronate-2-sulphatase conformation.

Parkinson-Lawrence E, Turner C, Hopwood J, Brooks D. Parkinson-Lawrence E, et al. Biochem J. 2005 Mar 1;386(Pt 2):395-400. doi: 10.1042/BJ20040739. Biochem J. 2005. PMID: 15500445 Free PMC article.

7

Mass spectrometric quantification of glycogen to assess primary substrate accumulation in the Pompe mouse.

Fuller M, Duplock S, Turner C, Davey P, Brooks DA, Hopwood JJ, Meikle PJ. Fuller M, et al. Anal Biochem. 2012 Feb 15;421(2):759-63. doi: 10.1016/j.ab.2011.12.026. Epub 2011 Dec 20. Anal Biochem. 2012. PMID: 22239964

8

Risk Management-Obstetrics and Gynecology Perspective.

Painter LM, Biggans KA, Turner CT. Painter LM, et al. Among authors: turner ct. Clin Obstet Gynecol. 2023 Jun 1;66(2):331-341. doi: 10.1097/GRF.0000000000000775. Epub 2023 Apr 4. Clin Obstet Gynecol. 2023. PMID: 37036733

9

Granzyme B Contributes to Choroidal Neovascularization and Age-Related Macular Degeneration Through Proteolysis of Thrombospondin-1.

Obasanmi G, Zeglinski MR, Hardie E, Wilhelm AC, Turner CT, Hiroyasu S, Boivin WA, Tian Y, Zhao H, To E, Cui JZ, Xi J, Yoo HS, Uppal M, Granville DJ, Matsubara JA. Obasanmi G, et al. Among authors: turner ct. Lab Invest. 2023 Jun;103(6):100123. doi: 10.1016/j.labinv.2023.100123. Epub 2023 Feb 26. Lab Invest. 2023. PMID: 36849037 Free article.

10

Granzyme K contributes to endothelial microvascular damage and leakage during skin inflammation.

Turner CT, Zeglinski MR, Boivin W, Zhao H, Pawluk MA, Richardson KC, Chandrabalan A, Bird P, Ramachandran R, Sehmi R, Lima H, Gauvreau G, Granville DJ. Turner CT, et al. Br J Dermatol. 2023 Aug 24;189(3):279-291. doi: 10.1093/bjd/ljac017. Br J Dermatol. 2023. PMID: 36652225

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page